Page last updated: 2024-09-05

copper tetrabenzo(b,f,j,n)-1,5,9,13-tetraazacyclohexadecine and Leukemia L 1210

copper tetrabenzo(b,f,j,n)-1,5,9,13-tetraazacyclohexadecine has been researched along with Leukemia L 1210 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dovinová, I; Hanusovská, E; Hunáková, L; Paulíková, H; Rauko, P; Tibenská, E1
Dovinová, I; Duracková, Z; Jantová, S; Labuda, J; Novotný, L; Urbancíková, M; Wsolová, L1

Other Studies

2 other study(ies) available for copper tetrabenzo(b,f,j,n)-1,5,9,13-tetraazacyclohexadecine and Leukemia L 1210

ArticleYear
Main targets of tetraaza macrocyclic copper complex on L1210 murine leukemia cells.
    Toxicology in vitro : an international journal published in association with BIBRA, 2002, Volume: 16, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Division; Cell Membrane; Copper; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flow Cytometry; Glutathione; Leukemia L1210; Mice; Organometallic Compounds; Oxidative Stress; Tumor Cells, Cultured

2002
Macrocyclic Cu(II)tetraanhydroaminobenzaldehyde complex--antiproliferative activity in vitro and in vivo.
    Neoplasma, 1998, Volume: 45, Issue:4

    Topics: Animals; Antineoplastic Agents; Benzaldehydes; Carcinoma, Hepatocellular; Cell Division; Cell Membrane; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Screening Assays, Antitumor; Fibroblasts; Growth Inhibitors; HeLa Cells; Humans; Leukemia L1210; Liver Neoplasms; Male; Mice; Mice, Inbred DBA; Neoplasm Proteins; Organometallic Compounds; Proteins; Tumor Cells, Cultured

1998